New Chief Scientific Officer and Senior Scientific Staff Hired by Advanced Viral Research Corp.

YONKERS, N.Y.--(BUSINESS WIRE)--Advanced Viral Research Corp. (OTCBB: ADVR), a research based biopharmaceutical company dedicated to anti-cancer drug discovery and development, today announced the appointment of Vincent P. Gullo, Ph.D., as Chief Scientific Officer, Dallas E. Hughes, Ph.D., as Vice President of Research, and Yuriy Dunayevskiy, Ph.D., as Research Fellow. The appointments follow ADVR’s recent acquisition of certain assets and proprietary technology of the former Cetek Corporation.

Back to news